The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans ...
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” ...
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA ...
Zacks Investment Research on MSN
Moderna's shares climb 5.3% as investors revisit biotech leaders
Shares of Moderna, Inc. MRNA rose 5.3% on Friday, Feb. 13, as investors showed renewed interest in large-cap biotech names. The gain stood out against a choppy broader market, suggesting traders were ...
Dow Jones Top Company Headlines at 5 AM ET: BlueScope Relegates Plans for U.S. Midstream Growth | Hapag-Lloyd ... BlueScope ...
Does President Donald Trump know that one of his top regulators is in the process of killing hundreds, maybe thousands, of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results